Informatie: Dit is niet de actueelste versie van het datamodel. Een versieoverzicht vindt u links onder Versies. De actueelste versie vindt u hier.
Informatie:
Fout:
ID
34541
Beschrijving
A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics; ODM derived from: https://clinicaltrials.gov/show/NCT02470481
Link
https://clinicaltrials.gov/show/NCT02470481
Trefwoorden
Versies (3)
- 19-01-19 19-01-19 -
- 11-02-20 11-02-20 - Christian Arras
- 04-03-20 04-03-20 - Christian Arras
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
19 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Psoriatic Arthritis NCT02470481
Eligibility Psoriatic Arthritis NCT02470481
- StudyEvent: Eligibility
Similar models
Eligibility Psoriatic Arthritis NCT02470481
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
patient must be a man or woman aged 18 to 65 years of age, inclusive
boolean
ID.2
Item
the patient must have an established diagnosis of psoriasis (based upon clinical evidence, and documented medical history [19])
boolean
ID.3
Item
the patient must be able to read and write in the target language (english, mandarin or korean; or other relevant target languages)
boolean
ID.4
Item
each patient must sign an informed consent form (icf) indicating that he or she understands the purpose of and procedures required for the study and are willing to participate in the study
boolean
ID.5
Item
an established diagnosis of psoriatic arthritis
boolean
ID.6
Item
ever have received systemic treatment with a disease modifying antirheumatic drug (dmard) for arthritis or spondylitis (inflammatory back pain)
boolean
ID.7
Item
ever have received systemic treatment with a biologic therapy for psoriasis (including infliximab, golimumab, ustekinumab, adalimumab or etanercept)
boolean
ID.8
Item
a history of employment in or are currently employed in the healthcare industry; or
boolean
ID.9
Item
participated in the translation and linguistic validation of the earp questionnaire
boolean